Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing

Clinical trial NCT04683068 · COMPLETED

Trial details

NCT number: NCT04683068
Sponsor: European Institute of Oncology
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

BRCA1 Mutation BRCA2 Mutation Psychosocial Factors

Start date: 2021-01-10
Primary completion: 2021-12-31
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.